Published in Int J Cancer on September 17, 1996
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol (2007) 1.47
Epithelial ovarian cancer experimental models. Oncogene (2013) 1.23
PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol (2000) 1.14
Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Res (2009) 1.06
Systems-level modeling of cancer-fibroblast interaction. PLoS One (2009) 0.94
Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems. Front Oncol (2014) 0.81
Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors. PLoS One (2013) 0.79
Pro-haloacetate Nanoparticles for Efficient Cancer Therapy via Pyruvate Dehydrogenase Kinase Modulation. Sci Rep (2016) 0.77
Non-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence Protein. PLoS One (2015) 0.76
The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts. BMC Med Imaging (2016) 0.75
Laminin-111 Peptides Conjugated to Fibrin Hydrogels Promote Formation of Lumen Containing Parotid Gland Cell Clusters. Biomacromolecules (2016) 0.75
Stiffened Extracellular Matrix and Signaling from Stromal Fibroblasts via Osteoprotegerin Regulate Tumor Cell Invasion in a 3-D Tumor in Situ Model. Cancer Microenviron (2016) 0.75
Brief interventions for alcohol problems: a review. Addiction (1993) 8.64
The most primitive osteichthyan braincase? Nature (2000) 4.91
The reliability of Form 90: an instrument for assessing alcohol treatment outcome. J Stud Alcohol (1997) 4.39
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol (2001) 4.09
Concentrations of parabens in human breast tumours. J Appl Toxicol (2004) 3.98
Estimating blood alcohol concentration: two computer programs and their applications in therapy and research. Addict Behav (1979) 3.73
Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet (1999) 2.91
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res (1987) 2.72
High resolution analysis of haplotype diversity and meiotic crossover in the human TAP2 recombination hotspot. Hum Mol Genet (2000) 2.67
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol (2009) 2.65
Meta-analysis of the literature on Alcoholics Anonymous: sample and study characteristics moderate findings. J Stud Alcohol (1996) 2.65
Effects of normative feedback on consumption among heavy drinking college students. J Drug Educ (1995) 2.38
Are problem drinkers dangerous drivers? An investigation of arrest for drinking and driving, serum gamma glutamyltranspeptidase activities, blood alcohol concentrations, and road traffic accidents: the Tayside Safe Driving Project. Br Med J (Clin Res Ed) (1985) 2.36
The cost effectiveness of treatment for alcoholism: a first approximation. J Stud Alcohol (1991) 2.13
Motivation for treatment: a review with special emphasis on alcoholism. Psychol Bull (1985) 2.03
Significance of aromatase activity in human breast cancer. Cancer Res (1982) 1.97
Does Alcoholics Anonymous involvement predict treatment outcome? J Subst Abuse Treat (1996) 1.81
Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer (1995) 1.81
A longitudinal model of intake symptomatology, AA participation and outcome: retrospective study of the project MATCH outpatient and aftercare samples. J Stud Alcohol (2001) 1.74
Metabolism and translocation of allantoin in ureide-producing grain legumes. Plant Physiol (1982) 1.68
Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet (2005) 1.68
Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol (1999) 1.60
Focused versus broad-spectrum behavior therapy for problem drinkers. J Consult Clin Psychol (1980) 1.56
De Novo Purine Synthesis in Nitrogen-Fixing Nodules of Cowpea (Vigna unguiculata [L.] Walp.) and Soybean (Glycine max [L.] Merr.). Plant Physiol (1982) 1.54
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature (1985) 1.53
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer (1996) 1.51
Relative effectiveness of bibliotherapy, individual and group self-control training in the treatment of problem drinkers. Addict Behav (1980) 1.43
Where to publish? Some considerations among English-language addiction journals. Addiction (1997) 1.42
Nipple aspirate fluid in relation to breast cancer. Breast (1999) 1.41
A human tumour model. Lancet (1986) 1.39
Steroid metabolism by human breast and rat mammary carcinomata. Steroids (1974) 1.36
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer (1990) 1.24
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. Cancer Res (1985) 1.22
Atheists, agnostics and Alcoholics Anonymous. J Stud Alcohol (2002) 1.21
Inpatient alcoholism treatment. Who benefits? Am Psychol (1986) 1.21
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol (2005) 1.18
Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br Med J (Clin Res Ed) (1988) 1.16
The community reinforcement approach to the treatment of substance use disorders. Am J Addict (2001) 1.15
Oestradiol synthesis by a human breast carcinoma. Lancet (1974) 1.15
Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br J Cancer (1994) 1.13
Depression and learned helplessness in man. J Abnorm Psychol (1975) 1.13
Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies. Br J Cancer (2002) 1.13
Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. J Steroid Biochem Mol Biol (2001) 1.13
Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling. J Cell Biol (1999) 1.12
Community reinforcement and family training (CRAFT): engaging unmotivated drug users in treatment. J Subst Abuse (1998) 1.11
Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res (1995) 1.10
The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease. Eur J Cancer Clin Oncol (1985) 1.10
Differences among AA groups: implications for research. J Stud Alcohol (1993) 1.09
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. Br J Cancer (2010) 1.09
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer. Cancer Res (2001) 1.09
Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours. Br J Cancer (2000) 1.08
Behavioral treatment of problem drinkers: a comparative outcome study of three controlled drinking therapies. J Consult Clin Psychol (1978) 1.08
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Br J Surg (1987) 1.07
The composition of intracellular granules from the metal-accumulating cells of the common garden snail (Helix aspersa). Biochem J (1981) 1.07
Risk factors for breast cancer. BMJ (1995) 1.07
Effectiveness of a self-control manual for problem drinkers with and without therapist contact. Int J Addict (1981) 1.06
Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa. Br J Cancer (1994) 1.06
Thrombospondin in malignant and non-malignant breast tissue. Eur J Cancer Clin Oncol (1989) 1.05
Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res (1987) 1.05
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa"). Br J Cancer (2002) 1.05
Drinking and thinking: how does personal drinking affect judgments of prevalence and risk? J Stud Alcohol (1994) 1.04
Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. Eur J Cancer (2000) 1.04
Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity. Br J Cancer (1986) 1.03
Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer (1996) 1.03
Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. Cancer Res (1992) 1.03
Raised alpha-fetoprotein levels in amniotic fluid and maternal serum associated with distension of the fetal bladder caused by absence of urethra. J Med Genet (1978) 1.01
In vitro effects of oestrogen on 5alpha reduction of testosterone in hormone-dependent rat mammary carcinomata. Br J Cancer (1976) 1.01
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol (1994) 1.01
Peer-managed self-control program for prevention of alcohol abuse in American Indian high school students: a pilot evaluation study. Int J Addict (1985) 1.00
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. Clin Cancer Res (1998) 0.99
Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. Blood (1999) 0.99
Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity. Eur J Cancer Clin Oncol (1985) 0.99
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer (1990) 0.99
Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Res Treat (1997) 0.98
Metabolism of androgens by human breast tissue. Lancet (1973) 0.98
Psychological deficit in depression. Psychol Bull (1975) 0.98
c-erbB growth-factor-receptor proteins in ovarian tumours. Int J Cancer (1995) 0.97
Transforming growth factor-beta isoform expression in human ovarian tumours. Eur J Cancer (1997) 0.97
c-erbB-3 protein expression in ovarian tumours. Br J Cancer (1995) 0.97
The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study. Clin Cancer Res (2000) 0.97
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model. Eur J Cancer (1994) 0.97
Intercessory prayer in the treatment of alcohol abuse and dependence: a pilot investigation. Altern Ther Health Med (1997) 0.97
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment. Endocr Relat Cancer (2005) 0.97
The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res Treat (1991) 0.97
Steroid metabolism and oestrogen receptors in human breast carcinomas. Eur J Cancer Clin Oncol (1981) 0.96
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. Br J Cancer (2009) 0.96
Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol (1995) 0.96
"In vivo" determination of hip joint separation and the forces generated due to impact loading conditions. J Biomech (2001) 0.96
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer. Ann Oncol (1999) 0.95
Oestradiol synthesis from C19 steroids by human breast cancers. Br J Cancer (1976) 0.95
Cyclic AMP binding proteins in human breast cancer. Br J Cancer (1985) 0.95
Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. Br J Cancer (1989) 0.95
Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological features. Clin Cancer Res (1996) 0.95
Comparison of outcomes for clients in randomized versus open trials of treatment for alcohol use disorders. J Stud Alcohol (2000) 0.95